Benzyl Bromide

Benzyl Bromide

SCHEMBL1233938

BrCc1ccccc1.BrCc1ccccc1.CC(C)=O.CC(C)=O

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.70
TSHR P16473 2/20 0.70
TRPA1 O75762 1/20 0.70
CES2 O00748 2/20 0.59
CES1 P23141 2/20 0.59
LMNA P02545 2/20 0.48
AKR1B1 P15121 1/20 0.48
ALPI P09923 1/20 0.45
PKM P14618 1/20 0.45
PTGS1 P23219 1/20 0.45
XIAP P98170 1/20 0.45
SLC7A5 Q01650 1/20 0.45
PTPN1 P18031 1/20 0.44
GSK3B P49841 1/20 0.44
KEAP1 Q14145 1/20 0.44
CYP2C9 P11712 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CYP1A2 P05177 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzyl Bromide SCHEMBL1233939 1.00 ALDH1A1 (0.70) ALDH1A1TSHRTRPA1CES2CES1
Benzyl Bromide SCHEMBL9087122 0.95 ALDH1A1 (0.70) ALDH1A1TSHRTRPA1CES2CES1
Benzyl Bromide SCHEMBL7951960 0.90 ALDH1A1 (0.78) ALDH1A1TSHRTRPA1CES2CES1
Benzyl Bromide SCHEMBL28152944 0.87 ALDH1A1 (0.74) ALDH1A1TSHRTRPA1CES2CES1
Benzyl Bromide SCHEMBL27618232 0.87 ALDH1A1 (0.74) ALDH1A1TSHRTRPA1CES2CES1
Benzyl Bromide SCHEMBL28763610 0.87 ALDH1A1 (0.82) ALDH1A1TSHRTRPA1CES2CES1
Benzyl Bromide SCHEMBL28343522 0.87 ALDH1A1 (0.58) ALDH1A1TSHRTRPA1CES2CES1
Benzyl Bromide SCHEMBL27520612 0.85 ALDH1A1 (0.70) ALDH1A1TSHRTRPA1CES2CES1
Benzyl Bromide SCHEMBL1331189 0.84
Benzyl Bromide SCHEMBL5757393 0.84 TSHR (1.00) ALDH1A1TSHRTRPA1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9115153-B2 Aza metal complexes CANON KABUSHIKI KAISHA (JP) 2015-08-25 US disclosed
US-20140275521-A1 Aza metal complexes CANON KABUSHIKI KAISHA (JP) 2014-09-18 US disclosed
US-8772475-B2 AZA compounds and production method thereof, and metal complexes as MRI contrast agents CANON KABUSHIKI KAISHA (JP) 2014-07-08 US disclosed
US-20110028713-A1 AZA COMPOUNDS AND PRODUCTION METHOD THEREOF, AND METAL COMPLEXES AS MRI CONTRAST AGENTS KYOTO UNIVERSITY (JP) 2011-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275521-A1 Aza metal complexes DNMT1, HDAC10, AZI2 ALDH1A1 3364/4885TSHR 1884/4885TRPA1 4125/4885
US-20110028713-A1 AZA COMPOUNDS AND PRODUCTION METHOD THEREOF, AND METAL COMPLEXES AS MRI CONTRAST AGENTS DNMT1, AZI2, HDAC10 ALDH1A1 2979/4885TSHR 1688/4885TRPA1 3888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.